NIH-funded research R01 grant

Understanding how to slow bone destruction in inflammatory arthritis

Official title: Negative Regulation of Osteoclastogenesis

Funded at Hospital for Special Surgery · NIH-11377415 · Data updated 2026-11-12

This NIH grant studies how inflammation drives bone loss and tests new ways to stop osteoclasts from breaking down bone in conditions like rheumatoid arthritis.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionHospital for Special Surgery
NIH-funded
Lab location1 site (New York, UNITED STATES)
Project startAugust 1, 2024
Project endJuly 31, 2029
Funding year2026
Award (this year)$551,137
NIH project number5R01AR084248-17
Project IDNIH-11377415 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are people with inflammatory arthritis or patients at risk for inflammatory bone loss who may benefit from future therapies derived from this research.

Less likely to help

Patients without inflammatory bone loss or related conditions may not directly benefit from this line of research.

What this research studies

If funded, researchers will explore the molecular signals that control bone-resorbing cells during inflammation and test new strategies to suppress their activity. The work builds on prior findings about epigenetic and metabolic controls of osteoclast formation in arthritis and implant-related bone loss. It aims to translate these basic insights into potential therapies that reduce pathological bone loss where current treatments fall short. The project includes models of inflammatory bone loss such as rheumatoid arthritis and orthopedic infections to assess potential treatments in relevant settings.

Why it matters

Potential benefit: Potentially new therapies could better prevent bone loss and joint damage in inflammatory diseases and after joint replacement.

How similar studies have gone: Previous work showed that inflammation and hypoxia regulate osteoclast formation, supporting the relevance of this approach; translation to therapies remains ongoing.

Where this research is happening

  • Hospital for Special Surgery
    New York, United States
    Active

Researchers

  • Principal investigator: Ivashkiv, Lionel B — Hospital for Special Surgery
  • Study coordinator: Ivashkiv, Lionel B

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.